EATG » Cure

Cure

AIDS 2018: Trial of ‘kick and kill’ approach to HIV cure leaves puzzles to be solved

24 July 2018 - Researchers have reported the results of the first randomised clinical trial to test a novel strategy. The approach involves waking up and then killing the ‘sleeping’…

2018 TAG Pipeline Report

Treatment Action Group (TAG) released the 2018 Pipeline Report - TAG’s annual review of therapeutics, diagnostics, vaccines, and preventive technologies in development for HIV, HCV, and TB, along with immune-based…

Latest issue of Journal of Virus Eradication now online

The Journal of Virus Eradication provides a specialist, open-access forum and fast-track pathway to publish work in the rapidly developing field of virus eradication, particularly of HIV, HBV and HCV.…

Abivax releases positive top line data from ABX464-005 phase 2a study in HIV infection

-- Extended dosing with ABX464 observed to be safe and well-tolerated. -- Decrease in Total HIV DNA in blood observed with longer treatment. -- For the first time, HIV DNA…

What’s the fuss about a functional cure?

A cautious overview of the Hong Kong study by Miranda Smith A recent study from researchers in Hong Kong has got the world’s media talking about a functional cure for HIV.…

EHVA: a clinical trial for therapeutic vaccination for HIV is about to start

Today and tomorrow EATG is attending the European HIV Vaccine Alliance (EHVA) consortium meeting in Barcelona. The EATG is one of the 39 partners of the consortium that aims to develop…

Strategies for a cure

Three researchers talk with Positively Aware editor Jeff Berry about ongoing HIV cure research within the ACTG, treatment interruptions, and when we might see a cure. Read the full interview…

T cells alone are sufficient to establish and maintain HIV infection in the brain

These results indicate that T cells in the brain may be an important reservoir for HIV in patients that should be targeted by HIV cure approaches. CHAPEL HILL, NC, June…

Discovery of how HIV hedges its bets opens the door to new therapies

Scientists at Gladstone reveal how the virus decides between fates SAN FRANCISCO, CA, May 10, 2018 — A stem cell is one with infinite possibilities. So, for decades, scientists have…

Study challenges ‘shock and kill’ approach to eliminating HIV

Researchers have provided new insight into the cellular processes behind the 'shock and kill' approach to curing HIV, which they say challenges the effectiveness of the treatment. Their study, published…